Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease
Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have...
Gespeichert in:
Veröffentlicht in: | Digestive diseases and sciences 2015-05, Vol.60 (5), p.1152-1168 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1168 |
---|---|
container_issue | 5 |
container_start_page | 1152 |
container_title | Digestive diseases and sciences |
container_volume | 60 |
creator | Malgras, Brice Pautrat, Karine Dray, Xavier Pasquier, Pierre Valleur, Patrice Pocard, Marc Soyer, Philippe |
description | Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons. |
doi_str_mv | 10.1007/s10620-014-3421-y |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680757523</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712943953</galeid><sourcerecordid>A712943953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</originalsourceid><addsrcrecordid>eNp1kc2OFCEUhYnROO3oA7gxlbhxUyMXCiiWkx5nNJmJCzUuCQVUy6QKWqAWvfM1fD2fRDo1_kbDAsL9zuFeDkJPAZ8BxuJlBswJbjF0Le0ItId7aANM0JYw3t9HGwy8ngH4CXqU8y3GWArgD9EJYbQHgukGfbxZpuKtz8bvJx90OjQ3Ouidm10oTRybK51Lij4Ul0utT82lH1Is3jTvigsx-9z40GxT_BS-ffmamwufnc7uMXow6im7J3f7Kfpw-er99nV7_fbqzfb8ujVMsNJCPwy207brHTDJAaw1nRwkHySVZBiEIZLLznIipXGCUwLCYbBMaMYps_QUvVh99yl-XmqPaq6zuGnSwcUlK-A9FvUpQiv6_C_0Ni6pjrRSgKXs5C9qpyenfBhjSdocTdW5ACI7KtnR6-wfVF3Wzd7E4EZf7_8QwCowKeac3Kj2yc_1uxVgdQxTrWGqGqY6hqkOVfPsruFlmJ39qfiRXgXICuRaCjuXfpvov67fAdd3qRo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680109949</pqid></control><display><type>article</type><title>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Malgras, Brice ; Pautrat, Karine ; Dray, Xavier ; Pasquier, Pierre ; Valleur, Patrice ; Pocard, Marc ; Soyer, Philippe</creator><creatorcontrib>Malgras, Brice ; Pautrat, Karine ; Dray, Xavier ; Pasquier, Pierre ; Valleur, Patrice ; Pocard, Marc ; Soyer, Philippe</creatorcontrib><description>Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-014-3421-y</identifier><identifier>PMID: 25381203</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biochemistry ; Care and treatment ; Combined Modality Therapy ; Constriction, Pathologic ; Crohn Disease - diagnosis ; Crohn Disease - epidemiology ; Crohn Disease - therapy ; Diagnostic Imaging - methods ; Digestive System Surgical Procedures - adverse effects ; Endoscopy, Gastrointestinal ; Fibrosis ; Gastroenterology ; Gastrointestinal Agents - adverse effects ; Gastrointestinal Agents - therapeutic use ; Gastrointestinal diseases ; Gastrointestinal system ; Health aspects ; Hepatology ; Humans ; Immunosuppressive Agents - adverse effects ; Immunosuppressive Agents - therapeutic use ; Intestinal Obstruction - diagnosis ; Intestinal Obstruction - epidemiology ; Intestinal Obstruction - therapy ; Medicine ; Medicine & Public Health ; Oncology ; Patient Care Team ; Predictive Value of Tests ; Recurrence ; Review ; Risk Factors ; Stenosis ; Transplant Surgery ; Treatment Outcome</subject><ispartof>Digestive diseases and sciences, 2015-05, Vol.60 (5), p.1152-1168</ispartof><rights>Springer Science+Business Media New York 2014</rights><rights>COPYRIGHT 2015 Springer</rights><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</citedby><cites>FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10620-014-3421-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10620-014-3421-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25381203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malgras, Brice</creatorcontrib><creatorcontrib>Pautrat, Karine</creatorcontrib><creatorcontrib>Dray, Xavier</creatorcontrib><creatorcontrib>Pasquier, Pierre</creatorcontrib><creatorcontrib>Valleur, Patrice</creatorcontrib><creatorcontrib>Pocard, Marc</creatorcontrib><creatorcontrib>Soyer, Philippe</creatorcontrib><title>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><description>Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Care and treatment</subject><subject>Combined Modality Therapy</subject><subject>Constriction, Pathologic</subject><subject>Crohn Disease - diagnosis</subject><subject>Crohn Disease - epidemiology</subject><subject>Crohn Disease - therapy</subject><subject>Diagnostic Imaging - methods</subject><subject>Digestive System Surgical Procedures - adverse effects</subject><subject>Endoscopy, Gastrointestinal</subject><subject>Fibrosis</subject><subject>Gastroenterology</subject><subject>Gastrointestinal Agents - adverse effects</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Gastrointestinal diseases</subject><subject>Gastrointestinal system</subject><subject>Health aspects</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Intestinal Obstruction - diagnosis</subject><subject>Intestinal Obstruction - epidemiology</subject><subject>Intestinal Obstruction - therapy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Patient Care Team</subject><subject>Predictive Value of Tests</subject><subject>Recurrence</subject><subject>Review</subject><subject>Risk Factors</subject><subject>Stenosis</subject><subject>Transplant Surgery</subject><subject>Treatment Outcome</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kc2OFCEUhYnROO3oA7gxlbhxUyMXCiiWkx5nNJmJCzUuCQVUy6QKWqAWvfM1fD2fRDo1_kbDAsL9zuFeDkJPAZ8BxuJlBswJbjF0Le0ItId7aANM0JYw3t9HGwy8ngH4CXqU8y3GWArgD9EJYbQHgukGfbxZpuKtz8bvJx90OjQ3Ouidm10oTRybK51Lij4Ul0utT82lH1Is3jTvigsx-9z40GxT_BS-ffmamwufnc7uMXow6im7J3f7Kfpw-er99nV7_fbqzfb8ujVMsNJCPwy207brHTDJAaw1nRwkHySVZBiEIZLLznIipXGCUwLCYbBMaMYps_QUvVh99yl-XmqPaq6zuGnSwcUlK-A9FvUpQiv6_C_0Ni6pjrRSgKXs5C9qpyenfBhjSdocTdW5ACI7KtnR6-wfVF3Wzd7E4EZf7_8QwCowKeac3Kj2yc_1uxVgdQxTrWGqGqY6hqkOVfPsruFlmJ39qfiRXgXICuRaCjuXfpvov67fAdd3qRo</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Malgras, Brice</creator><creator>Pautrat, Karine</creator><creator>Dray, Xavier</creator><creator>Pasquier, Pierre</creator><creator>Valleur, Patrice</creator><creator>Pocard, Marc</creator><creator>Soyer, Philippe</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150501</creationdate><title>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</title><author>Malgras, Brice ; Pautrat, Karine ; Dray, Xavier ; Pasquier, Pierre ; Valleur, Patrice ; Pocard, Marc ; Soyer, Philippe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c575t-18bbd4ad48e159611ddc49b96b9392bb7c29694d6299ce763217e01d57a5635d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Care and treatment</topic><topic>Combined Modality Therapy</topic><topic>Constriction, Pathologic</topic><topic>Crohn Disease - diagnosis</topic><topic>Crohn Disease - epidemiology</topic><topic>Crohn Disease - therapy</topic><topic>Diagnostic Imaging - methods</topic><topic>Digestive System Surgical Procedures - adverse effects</topic><topic>Endoscopy, Gastrointestinal</topic><topic>Fibrosis</topic><topic>Gastroenterology</topic><topic>Gastrointestinal Agents - adverse effects</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Gastrointestinal diseases</topic><topic>Gastrointestinal system</topic><topic>Health aspects</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Intestinal Obstruction - diagnosis</topic><topic>Intestinal Obstruction - epidemiology</topic><topic>Intestinal Obstruction - therapy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Patient Care Team</topic><topic>Predictive Value of Tests</topic><topic>Recurrence</topic><topic>Review</topic><topic>Risk Factors</topic><topic>Stenosis</topic><topic>Transplant Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malgras, Brice</creatorcontrib><creatorcontrib>Pautrat, Karine</creatorcontrib><creatorcontrib>Dray, Xavier</creatorcontrib><creatorcontrib>Pasquier, Pierre</creatorcontrib><creatorcontrib>Valleur, Patrice</creatorcontrib><creatorcontrib>Pocard, Marc</creatorcontrib><creatorcontrib>Soyer, Philippe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malgras, Brice</au><au>Pautrat, Karine</au><au>Dray, Xavier</au><au>Pasquier, Pierre</au><au>Valleur, Patrice</au><au>Pocard, Marc</au><au>Soyer, Philippe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>60</volume><issue>5</issue><spage>1152</spage><epage>1168</epage><pages>1152-1168</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Crohn’s disease (CD) is a chronic inflammatory bowel disease that can involve virtually any part of the gastrointestinal tract. CD complications are the main indications for surgery. A large proportion of these interventions are due to stricturing disease. Although immunosuppressive treatments have been used more frequently during the last 25 years, there is no significant decrease in the need for surgery in patients with CD. Unfortunately, surgery is not curative, as the disease ultimately reoccurs in a substantial subset of patients. To best identify the patients who will require a specific treatment and to plane the most appropriate therapeutic approach, it is important to precisely define the type, the size, and the location of CD stenosis. Diagnostic approaches aim to distinguish fibrotic from inflammatory strictures. Medical therapy is required for inflammatory stenosis. Mechanical treatments are required when fibrotic CD strictures are symptomatic. The choice between endoscopic balloon dilation, stricturoplasty, and laparoscopic or open surgery is based on the presence of perforating complications, the remaining length of small bowel, and the number and length of strictures. The non-hierarchical decision-making process for the treatment of fibrotic CD therefore requires multidisciplinary clinical rounds with radiologists, gastroenterologists, interventional endoscopists, and surgeons.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25381203</pmid><doi>10.1007/s10620-014-3421-y</doi><tpages>17</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-2116 |
ispartof | Digestive diseases and sciences, 2015-05, Vol.60 (5), p.1152-1168 |
issn | 0163-2116 1573-2568 |
language | eng |
recordid | cdi_proquest_miscellaneous_1680757523 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Biochemistry Care and treatment Combined Modality Therapy Constriction, Pathologic Crohn Disease - diagnosis Crohn Disease - epidemiology Crohn Disease - therapy Diagnostic Imaging - methods Digestive System Surgical Procedures - adverse effects Endoscopy, Gastrointestinal Fibrosis Gastroenterology Gastrointestinal Agents - adverse effects Gastrointestinal Agents - therapeutic use Gastrointestinal diseases Gastrointestinal system Health aspects Hepatology Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Intestinal Obstruction - diagnosis Intestinal Obstruction - epidemiology Intestinal Obstruction - therapy Medicine Medicine & Public Health Oncology Patient Care Team Predictive Value of Tests Recurrence Review Risk Factors Stenosis Transplant Surgery Treatment Outcome |
title | Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A26%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multidisciplinary%20Management%20of%20Gastrointestinal%20Fibrotic%20Stenosis%20in%20Crohn%E2%80%99s%20Disease&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Malgras,%20Brice&rft.date=2015-05-01&rft.volume=60&rft.issue=5&rft.spage=1152&rft.epage=1168&rft.pages=1152-1168&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1007/s10620-014-3421-y&rft_dat=%3Cgale_proqu%3EA712943953%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680109949&rft_id=info:pmid/25381203&rft_galeid=A712943953&rfr_iscdi=true |